🔎 Trials Near Me

Akèy › Sakom Ewing › Ohio

Etid klinik pou Sakom Ewing nan Ohio

8 etid pou Sakom Ewing ap chèche patisipan nan sit nan Ohio.

Vil nan Ohio

Tèks ofisyèl etid la (Anglè)

Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes

  • Cleveland Clinic Children's, Cleveland
  • Nationwide Children's Hospital, Columbus
Ap rekriteFaz 1
Laj 1 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07194044

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

  • Cincinnati Children's Hospital Medical Center, Cincinnati
Ap rekriteFaz 1
Laj 12 a 85 · Tout sèks · Mizajou Sep 8, 2026 · NCT03715933

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Cincinnati Children's Hospital Medical Center, Cincinnati
Ap rekriteFaz 1/2
12 Months – 30 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT04851119

Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas

  • Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT05210374

Single Arm Romiplostim to Prevent CIT

  • Cincinnati Children's Hospital Medical Center, Cincinnati
Ap rekriteFaz 1 bonè
Laj 1 ak plis · Tout sèks · Mizajou Mar 18, 2026 · NCT07048249

A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning

  • The Ohio State University Wexner Medical Center, Columbus
Ap rekrite
Laj 13 ak plis · Tout sèks · Mizajou Feb 6, 2026 · NCT06387485

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

  • Cincinnati Children's Hospital Medical Center, Cincinnati
  • Nationwide Children's Hospital, Columbus
Ap rekriteFaz 1/2
Laj 2 a 30 · Tout sèks · Mizajou Feb 3, 2026 · NCT05734066

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

  • Nationwide Children's Hospital, Columbus
Ap rekriteFaz 2
18 Months – 40 Years · Tout sèks · Mizajou Aug 12, 2025 · NCT05135975

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.